Document is current
Any future updates will be listed below
-
Authors
Ślusarczyk, Aleksander
Zapała, Piotr https://orcid.org/0000-0002-0569-4203
Zapała, Łukasz
Piecha, Tomasz
Radziszewski, Piotr
- License Information
-
More Information
Article History
Received: 21 March 2019
Accepted: 26 May 2019
First Online: 1 June 2019
Compliance with ethical standards
:
: Piotr Zapała, Łukasz Zapała, Tomasz Piecha and Piotr Radziszewski declare that they participate in clinical trial assessing efficacy and safety of durvalumab and receive fees as clinical investigators from AstraZeneca on that account.
